Identification of the primary site of metastatic adenocarcinoma in serous effusions: Value of an immunocytochemical panel added to the clinical arsenal

Acta Cytologica

Volumn 46, Issue 4, 2002, Pages 651-658

  Longatto Filho, Adhemar ^a   Alves, Venâncio Avancini Ferreira ^a   Kanamura, Cristina Takami ^a   Nonogaki, Suely ^a   Bortolan, Jeni ^a   Lombardo, Valeria ^a   Bisi, Helio ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Adenocarcinoma; Ascites; BRST 2; CA 125 antigen; CA 19.9 antigen; HBME 1; Immunocytochemistry; Lactoferrin; Neoplasm metastasis; Pleural effusion

Indexed keywords

BRST 2 ANTIGEN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; HBME 1 ANTIGEN; LACTOFERRIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; ASCITES FLUID; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER LOCALIZATION; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MESOTHELIOMA; OVARY ADENOCARCINOMA; PLEURA EFFUSION; PLEURA METASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 0036071245     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326970     Document Type: Article

References (35)

1. Diagnostic problems in serous effusions
2. Diagnosis and management of malignant pleural effusions
3. Adenocarcinoma in females detected in serous effusions: Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20
4. The use of avidin-biotin-peroxidase complex (ABC) in the immunoperoxidase technique: A comparison between ABC and unlabeled procedures
5. Immunocytochemical staining of cytologic specimens: How helpful is it?
6. Special stains: The old and the new: The impact of immunocytochemistry in effusion cytology
7. Immunocytochemistry in diagnostic pathology
8. Current status of tumor markers
9. Immunocytochemical identification of cells in serous effusions
10. Immunocytochemical staining of unstained versus previously stained cytologic preparations
11. Variability of immunohistochemical reactivity on stored paraffin slides
12. A scoring systems for immunocytochemical staining: Consensus report of the task force for basic research of the EORTC-GCCG
13. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers
14. Immunocytochemistry on cytologic specimens of limited quantity
15. The distribution of vimentin and cytokeratin in epithelial and non-epithelial cells
16. The contribution of immunocytochemistry in diagnostic cytology: Comparison and evaluation with immunohistology
17. The use of tumor markers in the management of patients with gynecologic carcinomas
18. Altered expression of CA-125 in breast carcinomas
19. Distribution of CA-125 in adenocarcinomas: An immunocytochemical study of 481 cases
20. OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma
21. CA-125 in fine needle aspirates of solid tumors: Comparison with cytologic diagnosis and carcinoembryonic antige (CEA) assay
22. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma: A diagnostic tool in the determination of primary site
23. Value of panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma
24. Distribution of carcinoma antigens CA 19.9 and CA 15.3
25. Use of tumor marker immunoreactivity to identify primary site of metastatic cancer
26. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites
27. Lactoferrin in thyroid lesions: Immunoreactivity in fine needle aspiration
28. Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system
29. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens
30. Mammary origin of metastases: Immunohistochemical determination
31. Caracterização de sítio primário de carcinomas metastáticos: Abordagem imunohistoquímica
32. HMBE-1, a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors
33. HBME-1 and thrombomodulin in the differential diagnosis of malignant mesothelioma of pleura
34. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumors: Preferential reactivity with malignant tumors